Curb Exosome Communications via Introducing Artificial Membrane Receptors for Metastatic Pancreatic Cancer Therapy

Targeting both tumor-derived exosomes and the primary tumor is challenging. Based on metabolic glycoengineering and bio-orthogonal click chemistry, a two-step delivery strategy was designed to overcome this.